Numbers

Claude View

The Numbers

Muthoot Capital trades at ₹194 – a 0.49x price-to-book discount that prices in structurally sub-par returns. The stock is down 47% from its 52-week high of ₹367. The single metric that will rerate or derate this stock is ROA: if Muthoot can sustain 2%+ ROA as AUM scales toward ₹10,000 Cr, the P/B re-rates to 1x+ and the stock doubles. If rising GNPA (now creeping back to 6.45%) signals another credit cycle blowup, the stock revisits its lows.

Valuation Snapshot

The stock trades at barely half its book value. TTM EPS of ₹7.43 gives a 26x P/E – optically expensive for a 7% ROE business, but the market is pricing in recovery earnings rather than trailing. The 52-week range of ₹175-367 reflects extreme sentiment swings: ₹367 was the optimism peak on AUM growth, and the slide back to ₹194 reflects rising NPAs and thin profitability.

Revenue and Earnings Power

Revenue has only returned to FY2021 levels after the COVID-era collapse. FY2024 net profit of ₹123 Cr was inflated by a ₹141 Cr one-time ARC sale recovery – normalized PAT was closer to ₹25 Cr. FY2025 PAT of ₹46 Cr on ₹474 Cr revenue represents the true run-rate earnings power at current scale.

Revenue has shown strong sequential growth – from ₹98 Cr in Q4 FY2024 to ₹155 Cr in Q3 FY2026, a 58% increase in 8 quarters. But profitability has not kept pace: Q1 FY2026 saw a net loss of ₹4.7 Cr as provisions surged, and even the latest Q3 FY2026 PAT of ₹7.7 Cr represents just a 5% margin. Excluding the Q2 FY2024 ARC recovery (₹83 Cr), quarterly PAT has averaged roughly ₹10 Cr – well below the level needed for acceptable returns.

The ROE Problem – Why the Stock is Cheap

Balance Sheet – Leverage Ramp

Debt-to-equity jumped from 2.72x to 4.34x in FY2025 as the company ramped AUM aggressively. Borrowings nearly doubled from ₹1,660 Cr to ₹2,855 Cr. This leverage buildup is the fuel for growth, but it also compresses ROE if the incremental lending yields do not cover the credit and operating costs. CRAR at 22.25% provides regulatory headroom, but the speed of leverage deployment demands flawless execution on credit quality.

Credit Quality – The Make-or-Break Metric

This is the single most important chart in this report. The post-ARC cleanup brought GNPA from 21% to under 5%, but the reversal since Q3 FY2025 signals that the fresh book being originated is not yet performing cleanly enough to offset seasoning losses. If GNPA stabilizes at 6-7%, the economics may hold. If it climbs past 8%, the FY2022 playbook threatens to repeat.

P&L Composition – Where the Money Goes

Interest costs are growing in line with borrowings (₹258 Cr on ₹2,855 Cr debt = ~9% cost of funds). Operating expenses have been well controlled at ₹153 Cr – the Muthoot FinCorp branch-sharing model keeps costs lean. The vulnerability is clear from FY2022: when credit costs spike (embedded in the Expenses line), they consume the entire P&L. At ₹474 Cr revenue, even ₹50 Cr of incremental provisions wipes out most of the profit.

Financing Margin Compression

Financing margins have collapsed from 24-32% in early FY2023 to low single digits. The Q1 FY2026 negative margin (-4.9%) was driven by elevated provisions. Even at Q3 FY2026, the 3.7% margin leaves almost no room for error. For this to normalize, either yields must expand (management targeting 22%+), credit costs must decline, or both.

Peer Valuation – The ROE-P/B Relationship

The peer scatter tells the whole story: every NBFC trading above 1x book delivers 14%+ ROE. Muthoot Capital, at 7% ROE and 0.49x P/B, sits in no-man's-land. The re-rating math is straightforward – if ROE reaches 15%, peer comps suggest 1.5-2.0x P/B is achievable, implying ₹600-800 per share. But the market has seen this promise before (FY2019 ROE was 20%) and watched it evaporate.

Muthoot Capital's GNPA at 4.88% is nearly double the peer average of ~2.1%. It pays no dividend. Its market cap of ₹319 Cr is a rounding error relative to ₹559,682 Cr Bajaj Finance. The P/E of 26x is elevated for a 7% ROE business, underscoring that the market is pricing future recovery rather than current earnings.

Shareholding Structure

Promoter holding increased marginally to 63.33% in Q2 FY2026 – a mildly positive signal. Institutional interest remains negligible: FIIs at 1.4% and DIIs at 1.4%. The stock is essentially a promoter-controlled, retail-held micro-cap with minimal institutional validation. Any meaningful institutional buying would itself be a re-rating catalyst given the thin float.

EPS Trajectory and Per-Share Economics

EPS has ranged from -₹98 to +₹74 over 8 years. FY2024 EPS of ₹74.58 was inflated by the ARC recovery; normalized FY2025 EPS of ₹27.82 on a book value of ₹399 implies a return-on-equity of ~7%. The company has paid zero dividends since FY2017, reinvesting all capital into growth. At 0.49x book, shareholders would benefit more from buybacks than growth at sub-par returns – but that is not on the agenda.

Cash Flow – Lending Business Dynamics

For a lending NBFC, operating cash flow is structurally negative during growth phases – loan disbursements exceed repayments. FY2025's operating outflow of -₹1,096 Cr against ₹1,220 Cr of financing inflows confirms the aggressive book ramp. This is expected behavior, not a red flag, but it means the company is entirely dependent on continued access to wholesale funding markets. Any liquidity squeeze (IL&FS-style) would force a sharp contraction.

The Re-Rating Math

What the Numbers Confirm and Contradict

The numbers confirm Warren's thesis: Muthoot Capital is a binary bet on whether management can scale AUM while keeping credit costs in check. Revenue growth is strong and accelerating (quarterly revenue up 58% in 8 quarters), cost of funds is declining (8.8% in Q3 FY2026), and the branch-sharing model keeps opex lean.

What the numbers contradict: the timing. Rising GNPA (4.7% to 6.5% in three quarters) and collapsing financing margins (from 15% to 3.7%) suggest the credit cycle has not yet turned in Muthoot's favor. The FY2025 vintage has not fully seasoned, and early signs are mixed. TTM PAT of just ₹12 Cr on ₹3,585 Cr of assets is a 0.3% ROA – far below the 2% target.

Watch next quarter: Fresh slippage rate (target under 0.5%), GNPA trajectory (must stabilize below 7%), and whether Q4 FY2026 financing margin recovers above 10%. If all three align, the re-rating story becomes credible. If GNPA breaches 8%, expect the stock to retest its 52-week low.